Literature DB >> 19884542

Sorafenib-induced bilateral osteonecrosis of femoral heads.

Marielle Guillet1, Thomas Walter, Jean-Yves Scoazec, Thierry Vial, Catherine Lombard-Bohas, Jérôme Dumortier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19884542     DOI： 10.1200/JCO.2009.23.4252

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents.

Authors:  Olivier Mir; Romain Coriat; Thomas Gregory; Stanislas Ropert; Bertrand Billemont; François Goldwasser
Journal:  Invest New Drugs       Date:  2010-02-24       Impact factor: 3.850

2.  Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

Authors:  Jason Fangusaro; Sridharan Gururangan; Regina I Jakacki; Sue C Kaste; Stewart Goldman; Ian F Pollack; James M Boyett; Larry E Kun
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

3.  Bevacizumab-associated osteonecrosis of the femur and tibia.

Authors:  Leandro J C Oliveira; Felipe S N A Canedo; Karina P Sacardo; João V M Alessi; Felipe G Barbosa; Andrea K Shimada; Artur Katz
Journal:  Oxf Med Case Reports       Date:  2019-05-31

Review 4.  Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.

Authors:  L Lorusso; L Pieruzzi; M Gabriele; M Nisi; D Viola; E Molinaro; V Bottici; R Elisei; L Agate
Journal:  J Endocrinol Invest       Date:  2021-07-21       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.